LOW IGM CONCENTRATION PREDICTS TIME TO PROGRESSION OF MGUS TO MULTIPLE MYELOMA: RESULTS FROM A RETROSPECTIVE SINGLE CENTER STUDY

被引：0
|
作者：
Sapienza, G. [1 ]
Romano, A. [1 ]
Innorcia, S. [1 ]
Scalise, L. [1 ]
Calafiore, V. [1 ]
Martino, E. [1 ]
Garibaldi, B. [1 ]
Giamporcaro, S. [1 ]
Parisi, M. [1 ]
Del Fabro, V. [1 ]
Di Raimondo, F. [1 ]
Conticello, C. [1 ]
机构：
[1] AOU Policlin Catania, Div Ematol, Catania, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO033
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [21] Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases
    Qian, Jiejing
    Jin, Jie
    Luo, Hong
    Jin, Chunji
    Wang, Lei
    Qian, Wenbin
    Meng, Haitao
    HEMATOLOGY, 2017, 22 (08) : 472 - 476
  • [22] A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma
    Liu, Lawrence
    Fiala, Mark
    Gao, Feng
    King, Justin
    Goldsmith, Scott
    Wildes, Tanya M.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    Schroeder, Mark A.
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3043 - 3046
  • [23] Subanesthetic Sevoflurane Concentration during Low Flow Gas Delivery: A Retrospective Single Center Registry Study
    Needham, Matthew
    Santer, Peter
    Obeidat, Salameh S.
    Zucco, Liana
    Nabel, Sarah
    Schafer, Dillon
    Levy, Nadav
    Khany, Mitra
    Stewart, Catriona
    Kenza, Aysha Z.
    Suleiman, Aiman
    Pandit, Jaideep J.
    Pollard, Richard
    Ramachandran, Satya Krishna
    ANESTHESIA AND ANALGESIA, 2022, 134 : 784 - 785
  • [24] Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients-a single-center retrospective study
    Regidor, Bernard
    Goldwater, Marissa-Skye
    Wang, Jessica
    Bujarski, Sean
    Swift, Regina
    Eades, Benjamin
    Emamy-Sadr, Marsiye
    Eshagian, Shahrooz
    Schwartz, Gary
    Spektor, Tanya M.
    Berenson, James R.
    ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2061 - 2070
  • [25] The cost of multiple myeloma and its complications: A single-center study from Oran, Algeria
    Haouatti, Fairouz
    Belhadj, Ikram K.
    Goumidi, Ahlem
    Yafour, Nabil
    Toumi, Houari
    ANNALES PHARMACEUTIQUES FRANCAISES, 2024, 82 (04): : 654 - 662
  • [26] Efficacy and safety of autologous hematopoietic stem cell transplantation in elderly multiple myeloma patients:a single center retrospective study
    黄蓓晖
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (02) : 120 - 120
  • [27] The clinical course of multiple myeloma in the era of novel agents: a retrospective, single-center, real-world study
    Szabo, Agoston Gyula
    Iversen, Katrine Fladeland
    Moller, Soren
    Plesner, Torben
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E281 - E281
  • [28] Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center
    Xu, Shuiqing
    Chen, Wenming
    Li, Yanchen
    HEMATOLOGY, 2024, 29 (01)
  • [29] The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study
    Agoston Gyula Szabo
    Katrine Fladeland Iversen
    Sören Möller
    Torben Plesner
    Clinical Hematology International, 2019, 1 (4) : 220 - 228
  • [30] Analyzing the impact of type 1 and type 2 diabetes on patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM): A retrospective study at a tertiary care center
    Thirugnanasambandam, Ram Prakash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345